436 related articles for article (PubMed ID: 18606210)
1. The anti-diabetic AMPK activator AICAR reduces IL-6 and IL-8 in human adipose tissue and skeletal muscle cells.
Lihn AS; Pedersen SB; Lund S; Richelsen B
Mol Cell Endocrinol; 2008 Sep; 292(1-2):36-41. PubMed ID: 18606210
[TBL] [Abstract][Full Text] [Related]
2. AICAR stimulates adiponectin and inhibits cytokines in adipose tissue.
Lihn AS; Jessen N; Pedersen SB; Lund S; Richelsen B
Biochem Biophys Res Commun; 2004 Apr; 316(3):853-8. PubMed ID: 15033479
[TBL] [Abstract][Full Text] [Related]
3. Oligomeric resistin impairs insulin and AICAR-stimulated glucose uptake in mouse skeletal muscle by inhibiting GLUT4 translocation.
Jørgensen SB; Honeyman J; Oakhill JS; Fazakerley D; Stöckli J; Kemp BE; Steinberg GR
Am J Physiol Endocrinol Metab; 2009 Jul; 297(1):E57-66. PubMed ID: 19435854
[TBL] [Abstract][Full Text] [Related]
4. Activation of AMPK is essential for AICAR-induced glucose uptake by skeletal muscle but not adipocytes.
Sakoda H; Ogihara T; Anai M; Fujishiro M; Ono H; Onishi Y; Katagiri H; Abe M; Fukushima Y; Shojima N; Inukai K; Kikuchi M; Oka Y; Asano T
Am J Physiol Endocrinol Metab; 2002 Jun; 282(6):E1239-44. PubMed ID: 12006353
[TBL] [Abstract][Full Text] [Related]
5. Implication of S-adenosylhomocysteine hydrolase in inhibition of TNF-alpha- and IL-1beta-induced expression of inflammatory mediators by AICAR in RPE cells.
Qin S; Ni M; De Vries GW
Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1274-81. PubMed ID: 18326758
[TBL] [Abstract][Full Text] [Related]
6. Cytokine secretion by human adipocytes is differentially regulated by adiponectin, AICAR, and troglitazone.
Sell H; Dietze-Schroeder D; Eckardt K; Eckel J
Biochem Biophys Res Commun; 2006 May; 343(3):700-6. PubMed ID: 16563350
[TBL] [Abstract][Full Text] [Related]
7. Effect of fiber type and nutritional state on AICAR- and contraction-stimulated glucose transport in rat muscle.
Ai H; Ihlemann J; Hellsten Y; Lauritzen HP; Hardie DG; Galbo H; Ploug T
Am J Physiol Endocrinol Metab; 2002 Jun; 282(6):E1291-300. PubMed ID: 12006359
[TBL] [Abstract][Full Text] [Related]
8. Short-term AMP-regulated protein kinase activation enhances insulin-sensitive fatty acid uptake and increases the effects of insulin on fatty acid oxidation in L6 muscle cells.
Kelly KR; Abbott MJ; Turcotte LP
Exp Biol Med (Maywood); 2010 Apr; 235(4):514-21. PubMed ID: 20407084
[TBL] [Abstract][Full Text] [Related]
9. Acute and chronic treatment of ob/ob and db/db mice with AICAR decreases blood glucose concentrations.
Halseth AE; Ensor NJ; White TA; Ross SA; Gulve EA
Biochem Biophys Res Commun; 2002 Jun; 294(4):798-805. PubMed ID: 12061777
[TBL] [Abstract][Full Text] [Related]
10. AMP kinase activation ameliorates insulin resistance induced by free fatty acids in rat skeletal muscle.
Olsen GS; Hansen BF
Am J Physiol Endocrinol Metab; 2002 Nov; 283(5):E965-70. PubMed ID: 12376323
[TBL] [Abstract][Full Text] [Related]
11. Short-term adenosine monophosphate-activated protein kinase activator 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside treatment increases the sirtuin 1 protein expression in skeletal muscle.
Suwa M; Nakano H; Radak Z; Kumagai S
Metabolism; 2011 Mar; 60(3):394-403. PubMed ID: 20362304
[TBL] [Abstract][Full Text] [Related]
12. Acute exposure to AICAR increases glucose transport in mouse EDL and soleus muscle.
Balon TW; Jasman AP
Biochem Biophys Res Commun; 2001 Apr; 282(4):1008-11. PubMed ID: 11352652
[TBL] [Abstract][Full Text] [Related]
13. Impact of in vivo fatty acid oxidation blockade on glucose turnover and muscle glucose metabolism during low-dose AICAR infusion.
Christopher M; Rantzau C; Chen ZP; Snow R; Kemp B; Alford FP
Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E1131-40. PubMed ID: 16772328
[TBL] [Abstract][Full Text] [Related]
14. Prior serum- and AICAR-induced AMPK activation in primary human myocytes does not lead to subsequent increase in insulin-stimulated glucose uptake.
Al-Khalili L; Krook A; Zierath JR; Cartee GD
Am J Physiol Endocrinol Metab; 2004 Sep; 287(3):E553-7. PubMed ID: 15149951
[TBL] [Abstract][Full Text] [Related]
15. Targeting the AMP-activated protein kinase for the treatment of type 2 diabetes.
Musi N; Goodyear LJ
Curr Drug Targets Immune Endocr Metabol Disord; 2002 Jul; 2(2):119-27. PubMed ID: 12476786
[TBL] [Abstract][Full Text] [Related]
16. 5'-aminoimidazole-4-carboxyamide-ribonucleoside-activated glucose transport is not prevented by nitric oxide synthase inhibition in rat isolated skeletal muscle.
Stephens TJ; Canny BJ; Snow RJ; McConell GK
Clin Exp Pharmacol Physiol; 2004 Jul; 31(7):419-23. PubMed ID: 15236627
[TBL] [Abstract][Full Text] [Related]
17. Regulation of HSL serine phosphorylation in skeletal muscle and adipose tissue.
Watt MJ; Holmes AG; Pinnamaneni SK; Garnham AP; Steinberg GR; Kemp BE; Febbraio MA
Am J Physiol Endocrinol Metab; 2006 Mar; 290(3):E500-8. PubMed ID: 16188906
[TBL] [Abstract][Full Text] [Related]
18. Chronic activation of 5'-AMP-activated protein kinase changes myosin heavy chain expression in growing pigs.
Park SK; Sheffler TL; Spurlock ME; Grant AL; Gerrard DE
J Anim Sci; 2009 Oct; 87(10):3124-33. PubMed ID: 19617513
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of CYP2E1 induces HepG2 cells death by the AMP kinase activator 5'-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR).
Zhuge J
Cell Biol Toxicol; 2009 Jun; 25(3):253-63. PubMed ID: 18473182
[TBL] [Abstract][Full Text] [Related]
20. AMP kinase is not required for the GLUT4 response to exercise and denervation in skeletal muscle.
Holmes BF; Lang DB; Birnbaum MJ; Mu J; Dohm GL
Am J Physiol Endocrinol Metab; 2004 Oct; 287(4):E739-43. PubMed ID: 15165992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
